India Pharma Outlook

India Pharma Outlook Pharma Outlook provides the industry experts analysis of the key pressures facing the Pharma Industry in the year ahead

Novo Nordisk's Wegovy Gets India Nod for Teens Battling ObesityNovo Nordisk’s Wegovy has received approval in India for ...
29/05/2026

Novo Nordisk's Wegovy Gets India Nod for Teens Battling Obesity

Novo Nordisk’s Wegovy has received approval in India for teenagers struggling with obesity, opening a new treatment option for young patients aged 12 years and above.

Read More: https://lnkd.in/gB-wBvHk

Novo Nordisk

The Role of GLP-1 Pathways in Metabolic Health: Beyond PharmaceuticalsDr. Arunkanth Krishnakumar, Co-founder & CEO, Zeus...
28/05/2026

The Role of GLP-1 Pathways in Metabolic Health: Beyond Pharmaceuticals

Dr. Arunkanth Krishnakumar, Co-founder & CEO, ZeusHygia Lifesciences Pvt Ltd

Metabolic health is evolving beyond single-target solutions, and this article highlights how integrating GLP-1 pathways with multi-system approaches and advanced nutraceuticals is key to achieving sustainable, accessible, and long-term metabolic resilience.

Read More: https://lnkd.in/gQCVhjT2

Tata-Backed MedTherapy Claims CAR-T Breakthrough in One DayTata-backed MedTherapy Biotech claims a CAR-T breakthrough, m...
28/05/2026

Tata-Backed MedTherapy Claims CAR-T Breakthrough in One Day

Tata-backed MedTherapy Biotech claims a CAR-T breakthrough, marking what could be a major shift in cancer treatment manufacturing.

Read More: https://lnkd.in/g7NJKbFg

Tata Elxsi Unveils ViTel, AI Material Intelligence Solution for MedTecTata Elxsi has launched ViTel, an AI-driven materi...
27/05/2026

Tata Elxsi Unveils ViTel, AI Material Intelligence Solution for MedTec

Tata Elxsi has launched ViTel, an AI-driven material intelligence solution for medical device manufacturers, co-developed with Viridium AI.

Read More: https://lnkd.in/gBZriEkD

Vitel
Sreevatsa Sahasranaman, Senior Vice President and Head of Healthcare and Life Sciences at Tata Elxsi
Niraj Deo, chief executive officer, Viridium AI
Muthusamy Selvaraj, VP of Innovation and Partnerships at Tata Elxsi’s

Sun Pharma Q4 Revenue Rises 13.6%, Net Profit Jumps 26.2%Sun Pharma reported a strong financial performance for the four...
27/05/2026

Sun Pharma Q4 Revenue Rises 13.6%, Net Profit Jumps 26.2%

Sun Pharma reported a strong financial performance for the fourth quarter of FY26, with Sun Pharma Q4 revenue rising 13.6 per cent to Rs. 14,560 crore and Sun Pharma net profit jumping 26.2 per cent to Rs. 2,714 crore, reflecting healthy growth across key markets and businesses.

Read More: https://lnkd.in/gJacqJHp

Sun Pharmaceutical Industries Limited

Indian Pharma Deepens US Focus Despite Export DeclineIndia’s pharmaceutical companies are steadily strengthening their p...
26/05/2026

Indian Pharma Deepens US Focus Despite Export Decline

India’s pharmaceutical companies are steadily strengthening their presence in the US market, even as exports to the country saw a drop in the last financial year.

Read More: https://lnkd.in/gTA7HCr4

Sun Pharmaceutical Industries Limited
Zydus Hospitals

The Evolving Role of India as a Talent Hub for Healthcare R&DIn an interaction with Thiruamuthan, Assistant Editor at ,...
25/05/2026

The Evolving Role of India as a Talent Hub for Healthcare R&D

In an interaction with Thiruamuthan, Assistant Editor at , Suneela Thatte, VP and Head – Healthcare R&D for India, Merck Group, shares India’s transition from a cost-driven support hub to a strategic R&D innovator. She highlights the evolving capabilities, global integration, talent development, and the need for sustained collaboration to achieve leadership in healthcare innovation.

Read More: https://lnkd.in/gS7EvK7P

E-pharmacy in India 2026: Top Apps for Medicine DeliveryIndia’s healthcare landscape is undergoing a significant transfo...
25/05/2026

E-pharmacy in India 2026: Top Apps for Medicine Delivery

India’s healthcare landscape is undergoing a significant transformation with e-pharmacy at the centre. For millions of Indians, a smartphone and a few taps have replaced the trip to their neighborhood chemist and, in many cases, the doctor's clinic too.

Read More: https://lnkd.in/gBkuhy_T

➤ HealthKart
➤ PharmEasy
➤ Apollo Hospitals
➤ Reliance Industries Limited
➤ SastaSundar
➤Pradeep Dadha, CEO and founder, Netmeds.com
➤Haripriya G, Harigovind PC & Rakesh PS, Researchers, School of Legal Studies, CUSAT

By Anna Elzabeth Tom, Correspondent,

Immuneel Therapeutics CAR T Therapy Shows Two-Year Remission in CancerImmuneel Therapeutics CAR T-cell therapy has shown...
25/05/2026

Immuneel Therapeutics CAR T Therapy Shows Two-Year Remission in Cancer

Immuneel Therapeutics CAR T-cell therapy has shown two-year remission in patients with aggressive blood cancer, marking a notable clinical achievement and reinforcing the durability of locally developed advanced cell therapy in India.

Read More: https://lnkd.in/g6-dJJfj

Kiran Mazumdar-Shaw, Board Director and Co-founder & Amit Mookim, Board Director & CEO, Immuneel Therapeutics

Venus Remedies Strengthens GCC Presence with SFDA AuthorizationVenus Remedies has strengthened its footprint in the Gulf...
23/05/2026

Venus Remedies Strengthens GCC Presence with SFDA Authorization

Venus Remedies has strengthened its footprint in the Gulf region after receiving Marketing Authorization from the Saudi Food and Drug Authority for Plerixafor, a specialty injectable used in stem cell transplantation procedures.

Read More: https://lnkd.in/gXU42nJ8

➤ Saransh Chaudhary, President, Global Critical Care at Venus Remediesand CEO of Venus Medicine Research Centre (VMRC)
➤ Aditi K Chaudhary, President, International Business at Venus Remedies Limited

Indian CDMO 2.0 Guide: Risk-Sharing and Hybrid ModelsThe pharmaceutical outsourcing landscape is undergoing its most con...
22/05/2026

Indian CDMO 2.0 Guide: Risk-Sharing and Hybrid Models

The pharmaceutical outsourcing landscape is undergoing its most consequential structural transformation in decades and Indian CDMO players are leading the charge.

Read More: https://lnkd.in/gza36u72

➤ Rajendra Kumar Sahu, CEO & Jordi Robinson, CCO, Navin Molecular
➤ Dr. Satyanarayana Chava, CEO, Laurus Labs Limited
➤ Kiran Mazumdar Shaw, Executive Chairperson, Biocon & Syngene International Limited

By Zeenat Parween, Correspondent,

Address

Bangalore
560017

Website

Alerts

Be the first to know and let us send you an email when India Pharma Outlook posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to India Pharma Outlook:

Shortcuts

Share

Category